Recovery ⏱ Half-life: Short.

Vesugen

Vesugen (KED Peptide)

Buy from $29.99 →
Half-Life
Short.
Mol. Weight
~390 g/mol

What is Vesugen?

Vesugen is a synthetic tripeptide designed to support vascular endothelial function and microcirculation.

Research Applications

Endothelial function, vascular aging, microcirculation support, and cardiovascular research.

Dosage Information (Research Use)

10-20 mg/day for 10-30 day courses. Research use only.

Reconstitution & Handling

Standard.

Half-Life & Pharmacokinetics

Short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK, et al. “Short peptides modulate the effect of endonucleases.” Bull Exp Biol Med. 2006

How Vesugen Works

Vesugen modulates gene expression in endothelial cells, supporting vascular integrity and microcirculation.

Research Findings

Studied for cardiovascular aging, endothelial dysfunction, and microvascular health.

Dosage & Administration

10-20 mg/day for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Lys-Glu-Asp
Molecular Weight ~390 g/mol
Half-Life Short.
Available Sizes 5mg
Storage Lyophilized: -20°C.

Key Research References

  • Khavinson VK, et al. "Short peptides modulate the effect of endonucleases." Bull Exp Biol Med. 2006

Get Vesugen from SourcePeptides

Third-party tested • Research-grade purity • Fast US shipping

Shop Now →

Related Peptides

View all →
Recovery
FDA-approved synthetic analog of PTHrP that promotes bone formation and reduces fracture risk in postmenopausal osteoporosis.
Recovery
Thymus-targeting dipeptide bioregulator researched for immune system support and T-cell function restoration.
Recovery
Long-acting somatostatin analog for acromegaly and neuroendocrine tumors with convenient self-injectable depot formulation.